JP2003510078A5 - - Google Patents

Download PDF

Info

Publication number
JP2003510078A5
JP2003510078A5 JP2001526947A JP2001526947A JP2003510078A5 JP 2003510078 A5 JP2003510078 A5 JP 2003510078A5 JP 2001526947 A JP2001526947 A JP 2001526947A JP 2001526947 A JP2001526947 A JP 2001526947A JP 2003510078 A5 JP2003510078 A5 JP 2003510078A5
Authority
JP
Japan
Prior art keywords
glycoprotein
seq
polypeptide
nucleic acid
acid molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001526947A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003510078A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/026592 external-priority patent/WO2001023565A1/en
Publication of JP2003510078A publication Critical patent/JP2003510078A/ja
Publication of JP2003510078A5 publication Critical patent/JP2003510078A5/ja
Pending legal-status Critical Current

Links

JP2001526947A 1999-09-28 2000-09-28 Macacafascicularis由来のP−糖タンパク質およびその使用 Pending JP2003510078A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15692199P 1999-09-28 1999-09-28
US60/156,921 1999-09-28
US15881899P 1999-10-12 1999-10-12
US60/158,818 1999-10-12
PCT/US2000/026592 WO2001023565A1 (en) 1999-09-28 2000-09-28 P-glycoproteins from macaca fascicularis and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011284048A Division JP2012065671A (ja) 1999-09-28 2011-12-26 Macacafascicularis由来のP−糖タンパク質およびその使用

Publications (2)

Publication Number Publication Date
JP2003510078A JP2003510078A (ja) 2003-03-18
JP2003510078A5 true JP2003510078A5 (https=) 2007-11-29

Family

ID=26853651

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001526947A Pending JP2003510078A (ja) 1999-09-28 2000-09-28 Macacafascicularis由来のP−糖タンパク質およびその使用
JP2011284048A Withdrawn JP2012065671A (ja) 1999-09-28 2011-12-26 Macacafascicularis由来のP−糖タンパク質およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011284048A Withdrawn JP2012065671A (ja) 1999-09-28 2011-12-26 Macacafascicularis由来のP−糖タンパク質およびその使用

Country Status (6)

Country Link
US (2) US6617450B1 (https=)
EP (1) EP1220917A1 (https=)
JP (2) JP2003510078A (https=)
AU (1) AU7835600A (https=)
CA (1) CA2386029A1 (https=)
WO (1) WO2001023565A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002367884A1 (en) * 2001-03-19 2002-10-03 Gentest Corporation P-Glycoproteins and uses thereof
US20050153914A1 (en) * 2001-05-18 2005-07-14 Sirna Therapeutics, Inc. RNA interference mediated inhibition of MDR P-glycoprotein gene expression using short interfering nucleic acid (siNA)
EP1617888B1 (en) 2003-04-23 2019-06-12 Valeritas, Inc. Hydraulically actuated pump for long duration medicament administration
US20060084799A1 (en) * 2003-09-24 2006-04-20 Williams Lewis T Human cDNA clones comprising polynucleotides encoding polypeptides and methods of their use
WO2005056608A1 (en) * 2003-12-04 2005-06-23 University Of Utah Research Foundation Modified macromolecules and methods of making and using thereof
US20100330143A1 (en) 2003-12-04 2010-12-30 University Of Utah Research Foundation Modified macromolecules and methods of making and using thereof
WO2006014425A1 (en) 2004-07-02 2006-02-09 Biovalve Technologies, Inc. Methods and devices for delivering glp-1 and uses thereof
CN103239773B (zh) 2006-03-30 2015-08-26 瓦莱里塔斯公司 多筒式流体递送器械
ATE490344T1 (de) * 2006-07-14 2010-12-15 Govt Of The Usa As Represented By The Secretary Of The Dept Of Health And Human Services Abcbi-genotypisierung zur vorhersage der mikrotubuli-stabilisatorwirkstoffinduzierten toxizität
CN103124904B (zh) * 2010-09-27 2015-06-03 詹森生物科技公司 食蟹猴ccl17
WO2013010045A1 (en) 2011-07-12 2013-01-17 Biotime Inc. Novel methods and formulations for orthopedic cell therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005943A1 (en) * 1986-03-28 1987-10-08 Board Of Trustees Of University Of Illinois Compositions and methods for clones containing dna sequences associated with multidrug resistance in human cells
US5429921A (en) 1988-04-04 1995-07-04 The Salk Institute Biotechnology/Industrial Assoc. Inc. Assays for agonists and antagonists of recombinant human calcium channels
WO1993002105A1 (en) * 1991-07-19 1993-02-04 Hybritech Incorporated Trifunctional compounds having specificity for multi-drug resistant cells
WO1993024613A1 (en) * 1992-05-22 1993-12-09 The United States Government As Represented By The Secretary Of The Department Of Health And Human Services Improved expression of human multidrug resistance genes and improved selection of cells transduced with such genes
WO1998013072A1 (en) 1996-09-24 1998-04-02 Thomas Jefferson University Compositions for and methods of treating multiple drug resistance
AU4214799A (en) * 1998-05-28 1999-12-13 St. Jude Children's Research Hospital Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
AU6164599A (en) * 1998-09-25 2000-04-17 Wisconsin Alumni Research Foundation Xenobiotic detoxification gene from plants

Similar Documents

Publication Publication Date Title
US20230218743A1 (en) Peptide Therapeutics Against SARS-COV-2 Spike Protein
EP0483194B1 (en) IgG3 ANTIBODIES WITH SHORTENED HINGE REGION AND A COMPLEMENT ACTIVATION TEST
Zillikens et al. BP180/type XVII collagen: its role in acquired and inherited disorders or the dermal-epidermal junction
JP2002542157A5 (https=)
JP2005524385A5 (https=)
JP2003510078A5 (https=)
JP2006518991A5 (https=)
JP2008169227A (ja) Il8阻害剤
JP2008508861A5 (https=)
JP2003511007A5 (https=)
JP2003527109A5 (https=)
ATE393786T1 (de) Mit a33 vewandte antigene und deren pharmezeutische verwendung
JP2005519608A5 (https=)
JP2004513614A5 (https=)
JPWO2021007110A5 (https=)
JP5821198B2 (ja) 抗il28b抗体及びこれを用いたil28bの測定方法
JP2003510071A5 (https=)
JP2004515215A5 (https=)
JP2009523004A5 (https=)
JP2005512509A5 (https=)
KR101789910B1 (ko) 쇼그렌 증후군 진단 마커로서 siglec5의 용도
JP6882440B2 (ja) 抗il4−il13二重特異性抗体
JP2008509659A5 (https=)
US20020115115A1 (en) Uses of mammalian genes and related reagents
JP2004511208A5 (https=)